Eli Lilly & Co. has filed another infringement complaint against Teva Pharmaceuticals USA Inc. in the U.S. District Court for the Southern District of Indiana, over efforts to make a generic version of Lilly's cancer treatment Gemzar.
The details can be read here.
No comments:
Post a Comment